Role of Immunotherapy in Pulmonary Angiosarcoma: A Case Report

3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pulmonary angiosarcoma is a rare clinical entity with a poor prognosis and no established therapeutic strategies. We present the first case to our knowledge of metastatic pulmonary angiosarcoma, treated with checkpoint inhibitor immunotherapy, and have an excellent response. Until now, patient has been treated with immunotherapy for 1 year, and his disease is stable and well-tolerated.

Cite

CITATION STYLE

APA

Nguyen, Q. T., Pham, A. T., Nguyen, T. T., Nguyen, T. T. T., & Van Le, K. (2021). Role of Immunotherapy in Pulmonary Angiosarcoma: A Case Report. Case Reports in Oncology, 14(2), 797–801. https://doi.org/10.1159/000516402

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free